HomeTagsAngioDynamics

AngioDynamics

First Patient Enrolled in PATHFINDER I Registry

The PATHFINDER I Registry is a pilot study to evaluate the safety and efficacy of the Auryon Atherectomy System in the real-world treatment of de novo, re-stenotic, and in-stent restenosis lesions in infrainguinal arteries of patients with Peripheral Artery Diseases.

AngioDynamics Reported: DIRECT Clinical Study Receives Institutional Review Board Approval for the Treatment of Stage III Pancreatic Cancer

AngioDynamics announced that the Company received central Institutional Review Board (IRB) approval to conduct its NanoKnife® Irreversible Electroporation “Direct IRE Cancer Treatment” clinical study (DIRECT).

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version